Hyperthyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

Hyperthyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • November 2017 •
  • 79 pages •
  • Report ID: 5184167 •
  • Format: PDF
Hyperthyroidism is common form of thyroid disorders, results from overactive thyroid functioning and is mostly observed in women, old population and patients with other thyroid issues. Extra secretion of thyroid hormones leads to speed up of metabolism in the body. Accordingly, patients witness symptoms of anxiety, rapid heartbeat, shivering, excessive sweat excretion, weight loss and insomnia.

Auto-immune disorder including Graves’ disease is the common cause of the condition. The disease leads the body to produce anti-body termed thyroid-stimulating immunoglobulin (TSI). The TSI results in thyroid to secrete additional thyroid hormones. In addition, lumps on thyroid gland and arrhythmia medications are also observed to cause hyperthyroidism.

Treatment options vary from patient to patient based on the condition including medication to reduce T3 and T4 hormone secretion, radioiodine and surgery.

Hyperthyroidism clinical trials report from VPA Research provides comprehensive analysis and trends in global Hyperthyroidism disease clinical trials. The research work analyzes the evolution of Hyperthyroidism clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Hyperthyroidism treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner offering quick access to Hyperthyroidism clinical trials.

Major drugs under development in Hyperthyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.

Scope of the Report-
- Number of Hyperthyroidism clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Hyperthyroidism
- Both observational and interventional trials analyzed
- Success rates of trials are analyzed
- Trends in enrollment over the past ten years identified
- Leading sponsors of Hyperthyroidism clinical trials worldwide are listed

Reasons to Buy-
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.